Health
RUDN geneticist finds a bifidobacterial protein that can reduce inflammation in COVID-19 – News-Medical.Net
A geneticist from RUDN University studied the effect of Bifidobacterium (intestinal bacteria) on the inflammatory process and discovered that their surface protein is capable of stopping excessive or uncontrollable inflammation, like the one observed in COVID…
Reviewed by Emily Henderson, B.Sc.Sep 14 2020
A geneticist from RUDN University studied the effect of Bifidobacterium (intestinal bacteria) on the inflammatory process and discovered that their surface protein is capable of stopping excessive or uncontrollable inflammation, like the one observed in COVID-19 patients. A fragment of this protein can be used as an anti-inflammatory medication when treating coronavirus and other diseases. The results of the study were published in the Anaerobe jour…
-
Noosa News21 hours agoYoung voices shape Sunshine Coast’s future
-
Business20 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News20 hours agoQueensland government to review greenhouse gas emission reduction targets
-
Noosa News19 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here